XGES holdings
As of , XGES (MSCI Genomic Healthcare Innov UCITS ETF, ISIN IE000KD0BZ68) has 100 holdings on our record. The fund reports 104 positions in all. Weights are shares of the whole fund.
- Holdings
- 100
- 104 reported in all
- Ten largest
- 46.7%
- of the whole fund
- Effective number of holdings
- 32
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 6.0%
- Moderna
Largest holdings
| Rank by weight# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | ModernaMRNAHealth CareUnited States | 5.95% |
| 2 | Agilent TechnologiesAHealth CareUnited States | 4.99% |
| 3 | Lonza GroupLONNHealth CareSwitzerland | 4.95% |
| 4 | DanaherDHRHealth CareUnited States | 4.92% |
| 5 | IlluminaILMNHealth CareUnited States | 4.58% |
| 6 | RocheROHealth CareSwitzerland | 4.57% |
| 7 | NateraNTRAHealth CareUnited States | 4.45% |
| 8 | Vertex PharmaceuticalsVRTXHealth CareUnited States | 4.40% |
| 9 | GSK American Depository Shares RepHealth CareUnited Kingdom | 4.29% |
| 10 | argenxARGXHealth CareNetherlands | 3.61% |
The fund also holds 4 positions of under 0.005% each, about 0.0% of the fund together. They are not listed one by one.
All holdings
The fund publishes 104 holdings; the ten largest make up 46.7% of it.
Create a free account to see the full holdings list
Sign-up takes an email address. There is no card to enter and nothing to pay.
As of , holdings as published
More:XGES: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published on 15/11/2026 and change as the fund trades. This is information, not advice.